# Microwave Ablation for Treatment of Vascular Malformations: Efficacy and Safety

Study · id `cardio:ct-nct07404670` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07404670](<https://clinicaltrials.gov/study/NCT07404670>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07404670

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 150 participants.

## Technical summary

Registry record NCT07404670. Allocation not applicable; no masking; primary purpose treatment. Start 2026-03-01 (anticipated); primary completion 2028-03-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT07404670, source copy `cardio:ctgov-nct07404670-2026-02-11`, retrieved 2026-11-18)
- Planned start: 2026-03-01 (anticipated) (ClinicalTrials.gov record NCT07404670, source copy `cardio:ctgov-nct07404670-2026-02-11`, retrieved 2026-11-18)
- Primary completion: 2028-03-01 (anticipated) (ClinicalTrials.gov record NCT07404670, source copy `cardio:ctgov-nct07404670-2026-02-11`, retrieved 2026-11-18)
- Completion: 2028-03-01 (anticipated) (ClinicalTrials.gov record NCT07404670, source copy `cardio:ctgov-nct07404670-2026-02-11`, retrieved 2026-11-18)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07404670-2026-02-11`, retrieved 2026-11-18)

## The registry's words

- Brief title: Microwave Ablation for Treatment of Vascular Malformations: Efficacy and Safety
- Condition: Venous Malformations
- Condition: Arteriovenous Malformations
- Condition: Microwave Ablation
- Condition: Vascular Malformations
- Intervention (Device): Microwave Ablation
- Lead sponsor: Chengdu University of Traditional Chinese Medicine
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arteriovenous malformation (AVM) (`cardio:arteriovenous-malformation`)
- Registry lists this organization as the lead sponsor: Chengdu University of Traditional Chinese Medicine (`cardio:org-chengdu-university-of-traditional-chinese-medicine`)

## Provenance

Content hash: c014877830133dbad2b6e9607d3389b3a906bb4cc171893dd11e44c0c9d7dfd2
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
